Cargando…

The association between serum apolipoprotein B and fractional exhaled nitric oxide in bronchial asthma patients

BACKGROUND: Asthma and lipid metabolism are associated with systemic inflammation. However, the studies about the relationship between lipid profile, fractional exhaled nitric acid (FeNO) and pulmonary function test (PFT) results are currently lacking. METHODS: We enrolled asthma patients who had se...

Descripción completa

Detalles Bibliográficos
Autores principales: Heo, Jung Won, Lee, Hwa Young, Han, Solji, Kang, Hye Seon, Kwon, Soon Seog, Lee, Sook Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339740/
https://www.ncbi.nlm.nih.gov/pubmed/34422348
http://dx.doi.org/10.21037/jtd-20-3314
_version_ 1783733653648441344
author Heo, Jung Won
Lee, Hwa Young
Han, Solji
Kang, Hye Seon
Kwon, Soon Seog
Lee, Sook Young
author_facet Heo, Jung Won
Lee, Hwa Young
Han, Solji
Kang, Hye Seon
Kwon, Soon Seog
Lee, Sook Young
author_sort Heo, Jung Won
collection PubMed
description BACKGROUND: Asthma and lipid metabolism are associated with systemic inflammation. However, the studies about the relationship between lipid profile, fractional exhaled nitric acid (FeNO) and pulmonary function test (PFT) results are currently lacking. METHODS: We enrolled asthma patients who had serum lipid profiles including apolipoprotein levels from March 1, 2019 to December 31, 2019. We classified the asthma patients into two groups according to the diagnosis method: (I) patients who were diagnosed based on clinical symptoms/signs and PFT results and (II) patients diagnosed with clinical symptoms/signs. Clinical characteristics including age, underlying diseases, smoking status, allergy test results and treatment agents were compared between the two groups. The associations between blood cholesterol levels including apolipoprotein and pulmonary functions were analyzed. Moreover, patients were divided into two groups according to the median value of apolipoprotein B (Apo B), and lung function test results were compared between the patients who had high and low Apo B levels. RESULTS: Among the 167 patients, 93 (55.7%) were PFT-proven asthma patients. In PFT-proven asthma patients, the levels of total cholesterol (TC) (r =0.37, P=0.03), low-density lipoprotein (LDL) (r =0.46, P=0.01) and Apo B (r =0.38, P=0.02) showed a significant correlation with FeNO, which had no statistical significance in physician-diagnosed asthma group. In multivariate regression analysis, log (FeNO) showed a significant correlation with Apo B (P<0.01) after adjustment for presence of PFT-proven asthma (P=0.01) and current smoking (P=0.01). Patients with high Apo B levels had a lower post-bronchodilator (BD) forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) ratio (69.8 vs. 74.9, P=0.02) and lower post-BD FEV1 (%) (77.5 vs. 85.0, P=0.04) compared with those showing low Apo B levels. CONCLUSIONS: The levels of Apo B and FeNO had positive correlations and high Apo B levels were associated with severe airflow obstruction and low FEV1 (%). Apo B could reflect the uncontrolled status of bronchial asthma and poor lung function.
format Online
Article
Text
id pubmed-8339740
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-83397402021-08-20 The association between serum apolipoprotein B and fractional exhaled nitric oxide in bronchial asthma patients Heo, Jung Won Lee, Hwa Young Han, Solji Kang, Hye Seon Kwon, Soon Seog Lee, Sook Young J Thorac Dis Original Article BACKGROUND: Asthma and lipid metabolism are associated with systemic inflammation. However, the studies about the relationship between lipid profile, fractional exhaled nitric acid (FeNO) and pulmonary function test (PFT) results are currently lacking. METHODS: We enrolled asthma patients who had serum lipid profiles including apolipoprotein levels from March 1, 2019 to December 31, 2019. We classified the asthma patients into two groups according to the diagnosis method: (I) patients who were diagnosed based on clinical symptoms/signs and PFT results and (II) patients diagnosed with clinical symptoms/signs. Clinical characteristics including age, underlying diseases, smoking status, allergy test results and treatment agents were compared between the two groups. The associations between blood cholesterol levels including apolipoprotein and pulmonary functions were analyzed. Moreover, patients were divided into two groups according to the median value of apolipoprotein B (Apo B), and lung function test results were compared between the patients who had high and low Apo B levels. RESULTS: Among the 167 patients, 93 (55.7%) were PFT-proven asthma patients. In PFT-proven asthma patients, the levels of total cholesterol (TC) (r =0.37, P=0.03), low-density lipoprotein (LDL) (r =0.46, P=0.01) and Apo B (r =0.38, P=0.02) showed a significant correlation with FeNO, which had no statistical significance in physician-diagnosed asthma group. In multivariate regression analysis, log (FeNO) showed a significant correlation with Apo B (P<0.01) after adjustment for presence of PFT-proven asthma (P=0.01) and current smoking (P=0.01). Patients with high Apo B levels had a lower post-bronchodilator (BD) forced expiratory volume in 1 second (FEV1)/forced vital capacity (FVC) ratio (69.8 vs. 74.9, P=0.02) and lower post-BD FEV1 (%) (77.5 vs. 85.0, P=0.04) compared with those showing low Apo B levels. CONCLUSIONS: The levels of Apo B and FeNO had positive correlations and high Apo B levels were associated with severe airflow obstruction and low FEV1 (%). Apo B could reflect the uncontrolled status of bronchial asthma and poor lung function. AME Publishing Company 2021-07 /pmc/articles/PMC8339740/ /pubmed/34422348 http://dx.doi.org/10.21037/jtd-20-3314 Text en 2021 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Heo, Jung Won
Lee, Hwa Young
Han, Solji
Kang, Hye Seon
Kwon, Soon Seog
Lee, Sook Young
The association between serum apolipoprotein B and fractional exhaled nitric oxide in bronchial asthma patients
title The association between serum apolipoprotein B and fractional exhaled nitric oxide in bronchial asthma patients
title_full The association between serum apolipoprotein B and fractional exhaled nitric oxide in bronchial asthma patients
title_fullStr The association between serum apolipoprotein B and fractional exhaled nitric oxide in bronchial asthma patients
title_full_unstemmed The association between serum apolipoprotein B and fractional exhaled nitric oxide in bronchial asthma patients
title_short The association between serum apolipoprotein B and fractional exhaled nitric oxide in bronchial asthma patients
title_sort association between serum apolipoprotein b and fractional exhaled nitric oxide in bronchial asthma patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339740/
https://www.ncbi.nlm.nih.gov/pubmed/34422348
http://dx.doi.org/10.21037/jtd-20-3314
work_keys_str_mv AT heojungwon theassociationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients
AT leehwayoung theassociationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients
AT hansolji theassociationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients
AT kanghyeseon theassociationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients
AT kwonsoonseog theassociationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients
AT leesookyoung theassociationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients
AT heojungwon associationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients
AT leehwayoung associationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients
AT hansolji associationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients
AT kanghyeseon associationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients
AT kwonsoonseog associationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients
AT leesookyoung associationbetweenserumapolipoproteinbandfractionalexhalednitricoxideinbronchialasthmapatients